drugset / Trial / NCT01629875
Efficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar Line
RandomizedDouble-blindTreatment
Summary
The purpose of this study was to observe Efficacy and safety of DWP450 compared with Botox in moderate to severe glabellar line patients.
Timeline
- Start
- 2012-03
- Primary completion
- 2012-08
- Completion
- 2012-11
Outcome
Met primary endpoint
release “European and Canadian Phase III EVB-003 head-to-head comparative trial demonstrating that its investigational prabotulinumtoxinA 900 kilodalton (kDa) neuromodulator met its primary endpoint” evolus.com ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | — | — |
| Subject | PrabotulinumtoxinA | Protein / enzyme biologic | — | — |
Indications
No indication recorded.